Impact of heteroresistance on treatment outcomes of people with drug-resistant TB

Impact of heteroresistance on treatment outcomes of people with drug-resistant TB

BACKGROUND: Poor treatment outcomes among people with drug-resistant TB (DR-TB) are a major concern. Heteroresistance (presence of susceptible and resistant Mycobacterium tuberculosis in the same sample) has been identified in some people with TB, but its impact on treatment outcomes is unknown. MET...

Full description

Saved in:
Bibliographic Details
Main Authors: R. Crowder, M. Kato-Maeda, B. Schwem, A. dela Tonga, D.M. Geocaniga-Gaviola, E. Lopez, C.L. Valdez, A.R. Lim, N. Hunat, A.G. Sedusta, C.A. Sacopon, G.A.M. Atienza, E. Bulag, D. Lim, J. Bascuña, K. Shah, R.P. Basillio, C.A. Berger, M.C.D.P. Lopez, S. Sen, C. Allender, M. Folkerts, U. Karaoz, E. Brodie, S. Mitarai, A.M.C. Garfin, M.C. Ama, D.M. Engelthaler, A. Cattamanchi, R. Destura
Format: Article
Language:English
Published: International Union Against Tuberculosis and Lung Disease (The Union) 2024-10-01
Series:IJTLD Open
Subjects:
drug resistance-associated mutations
dr-tb
tuberculosis
Online Access:https://www.ingentaconnect.com/contentone/iuatld/ijtldo/2024/00000001/00000010/art00007
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items